Treatment With Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Alleviates the Severity of Streptozotocin-Induced Diabetes

OBJECTIVE: To evaluate the potential therapeutic effect of recombinant human tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) treatment in a model of type 1 diabetes. RESEARCH DESIGN AND METHODS: Recombinant TRAIL was added in vitro to primary human and mouse peripheral blood mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zauli, Giorgio, Toffoli, Barbara, di Iasio, Maria Grazia, Celeghini, Claudio, Fabris, Bruno, Secchiero, Paola
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857907/
https://www.ncbi.nlm.nih.gov/pubmed/20185810
http://dx.doi.org/10.2337/db09-1771

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2857907/
https://www.ncbi.nlm.nih.gov/pubmed/20185810
http://dx.doi.org/10.2337/db09-1771

Ejemplares similares